Topical Linalool Formulation for Bacterial Reduction Without Eye Irritation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibacterial preparations for the eye and eyelid area are either ineffective against bacterial colonization or cause clinically significant conditions, posing a risk of infection and irritation.
Innovation Solution
Topical preparations containing linalool and/or alpha-terpineol, combined with a membrane permeabilizer, provide bactericidal activity against both gram-negative and gram-positive bacteria without causing significant eye irritation, formulated to be clinically effective within acceptable exposure times.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibacterial preparations (triclocarban, triclosan, benzalkonium chloride, ethyl alcohol, alkyl dimethyl benzyl, ammonium chloride) are used, then bacterial killing activity is improved, but toxic effects and eye irritation worsen
Solution Approach 1:
The patent changes the chemical parameters by using linalool and alpha-terpineol as active ingredients instead of conventional antibacterials. These compounds are applied at specific concentrations (linalool: 0.1-5%, alpha-terpineol: 0.1-5%) to achieve effective bacterial killing while maintaining safety. The formulation also includes a membrane permeabilizer at optimized concentrations to enhance penetration and efficacy without increasing toxicity.
Solution Approach 2:
The patent creates a composite formulation combining linalool, alpha-terpineol, and a membrane permeabilizer in a single topical preparation. This composite approach synergistically enhances antibacterial activity against both gram-positive and gram-negative bacteria while the combined formulation maintains acceptable safety profiles, resolving the contradiction between efficacy and safety.
2Reliability
If tea tree oil is used at high concentrations for bactericidal activity, then bacterial killing is improved, but eye irritation worsens
Solution Approach 1:
The patent optimizes the concentration parameters of tea tree oil components (linalool and alpha-terpineol) to effective but safe levels. Linalool is used at 0.1-5% and alpha-terpineol at 0.1-5%, which provides sufficient bactericidal activity against ocular pathogens while staying below concentrations that cause significant eye irritation. The membrane permeabilizer further enhances efficacy at these lower concentrations.
3Reliability
If antibacterial soaps and cleansers are used, then bacterial reduction is improved, but clinical effectiveness within acceptable exposure times worsens
Solution Approach 1:
The patent changes the chemical composition parameters by incorporating a membrane permeabilizer that enhances the penetration and speed of action of linalool and alpha-terpineol. This allows the formulation to achieve significant bacterial reduction (at least 1 log reduction in CFUs) within 1 minute of exposure, making it clinically effective for quick eyelid hygiene applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The preparations achieve at least a 1 log reduction in colony-forming units of pathogens like Staphylococcus aureus and Pseudomonas aeruginosa within 1 minute, effectively reducing bacterial loads on the eyelids and ocular surfaces without causing irritation.
Implementation Method 1
Topical preparations containing linalool and/or alpha-terpineol, combined with a membrane permeabilizer, provide bactericidal activity against both gram-negative and gram-positive bacteria
Data Source
AI summary
The instant invention provides methods and compositions for the treatment of infection or infectious colonization of the eyelid and/or ocular surface for the treatment and prevention of ocular disorders and eyelid disorders.